AACR
The company presented three studies at the AACR annual meeting showcasing the performance of its amplification-based ASPYRE-Lung assay compared to NGS.
The company's technology, initially developed at UT Southwestern, sequences sets of T cell receptors that make up what it calls functional units.
Delfi Diagnostics' Liquid Biopsy Technology Shows Promise for Ovarian Cancer Screening
The test combining DNA fragmentomics and protein biomarkers had sensitivity ranging from 72 percent to 100 percent for detection of ovarian cancer, depending on disease stage.
Various presentations highlighted new data on validity, clinical impact, and novel platforms, as others attempted to analyze value.
At AACR's annual meeting, industry observers discussed how FDA's stance on RUOs amid its push to regulate LDTs is putting the "double squeeze" on the lab industry.